Health News Releases

February 10, 2021 18:20

Takeda Submits New Drug Application to Manufacture and Market Darvadstrocel In Japan for Treatment of Complex Perianal Fistulas in Adult Patients with Crohn’s Disease

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has submitted an application to the Japanese Ministry of Health, Labour and Welfare to manufacture and mark

February 10, 2021 17:28

MED™ 3D Printed Pharmaceutical Product Receives IND Clearance From the US FDA

Triastek, Inc. (“Triastek”), a pharmaceutical company specializing in 3D printing of drug products, announced today that the United States Food and Drug Administration (FDA) has approved its Investiga

February 10, 2021 15:30

Rhizen Pharmaceuticals AG Announces That Its Partnered Asset, Umbralisib (UKONIQ™), Has Received US FDA Accelerated Approval for Adult Patients With Relapsed or Refractory MZL & FL

Rhizen Pharmaceuticals, a clinical-stage oncology-focused biopharmaceutical company, today announced that its novel next generation PI3K-delta inhibitor, Umbralisib, which was licensed to TG Therapeut

February 09, 2021 14:30

ImmunoMet Therapeutics Receives IND Clearance and Orphan Drug Designation from U.S. FDA for IM156 in Ideopathic Pulmonary Fibrosis and Completes Financing

ImmunoMet Therapeutics, Inc., a clinical stage biotechnology company targeting metabolism to develop novel anti-fibrotic and anti-cancer therapies, today announced that the U.S. Food and Drug Administ

February 08, 2021 17:10

Diagnostic Flexibility at Your Fingertips with New, Versatile 12MP Diagnostic Display

Barco, a global leader in visualisation technology, has released a new 12MP healthcare diagnostic display system for picture archiving and communication systems (PACS) and breast imaging. The Nio Fusi

February 08, 2021 11:10

Takeda FY2020 Q3 Results Demonstrate Growth Acceleration and Continued Resilience; Full-Year Management Guidance for FY2020 Confirmed, Forecast Raised for Free Cash Flow and Reported EPS

Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) (“Takeda”) today announced financial results for the third quarter of fiscal year 2020 (period ended December 31, 2020). TAKEDA CHIEF FIN

February 08, 2021 09:54

Celltrion’s COVID-19 Treatment Candidate Receives Korean MFDS Conditional Marketing Authorisation

Celltrion Group today announced that the Korean Ministry of Food and Drug Safety (MFDS) granted a Conditional Marketing Authorisation (CMA) for the emergency use of Regdanvimab (CT-P59), an anti-COVID

February 03, 2021 18:08

Data at EAHAD 2021 Highlight Value of Takeda’s Leading Hematology Portfolio in Clinical Settings and Commitment to Patient-Focused Advancements

Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE:TAK) (“Takeda”) today announced that 14 abstracts from the company’s Hematology portfolio and pipeline are being presented as electronic posters a

February 03, 2021 14:30

Medigate Named Healthcare IoT Security Leader in 2021 Best in KLAS: Software & Services Report

Medigate, a healthcare dedicated device security and asset management company, today announced it was selected as the 2021 Best in KLAS for Healthcare IoT Security in the KLAS Software & Services Repo

February 03, 2021 11:15

Dexcom and Nick Jonas Unveil First-Ever Super Bowl Commercial, Calling for Better Care for People With Diabetes

DexCom, Inc. (NASDAQ:DXCM), the global leader in continuous glucose monitoring for people with diabetes, debuted today its first-ever Super Bowl commercial, starring multi-platinum recording artist, a

February 02, 2021 19:10

Vifor Pharma to propose Dr Alexandre LeBeaut as Board member

Regulatory News: Vifor Pharma today announced that the Board of Directors will propose Dr Alexandre LeBeaut for election to the Board at the next Annual General Meeting on 6 May 2021. Jacques Th

February 02, 2021 16:10

Jackson Memorial, Among World’s Largest Hospitals, Deploys Everbridge Software to Streamline COVID-19 Vaccine Distribution, Representing Growing Adoption in the Healthcare Industry

Everbridge, Inc. (NASDAQ: EVBG), the global leader in critical event management (CEM), today announced that a growing number of organizations across industry verticals, including healthcare and govern

February 01, 2021 16:45

Takeda Completes Sale of TachoSil® to Corza Health

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has completed the previously announced sale of TachoSil® Fibrin Sealant Patch (“TachoSil®”) to Corza Health

February 01, 2021 14:30

Takeda Completes Sale of Select OTC and Non-Core Assets to Hypera Pharma

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the completion of its previously-announced sale of a portfolio of select products sold in Latin America to Hypera S

January 29, 2021 14:00

Thousand Oaks Biopharmaceuticals Inked a Joint Venture Agreement with Korea’s WSG Group

January 2021, Thousand Oaks Biopharmaceuticals Group (“Thousand Oaks”) announced that it had signed a Joint Venture agreement with WSG Group in Busan, Korea, to establish a bioprocess solution joint v

January 29, 2021 13:10

Takeda Presents Positive Results For Mobocertinib in Patients with EGFR Exon20 insertion+ mNSCLC Who Received Prior Platinum-based Chemotherapy

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced new data from the Phase 1/2 trial of mobocertinib (TAK-788) orally administered in previously treated patients with

January 28, 2021 13:50

Takeda Achieved Carbon Neutrality in 2020

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it achieved carbon neutrality in its value chain for its fiscal year 2019. This achievement was delivered by a

January 27, 2021 13:20

Takeda Achieves Industry-Leading Positions in 2021 Access to Medicine Index

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) has earned an industry-leading position within the 2021 Access to Medicine (AtM) Index published today. Specifically the company ac

January 27, 2021 11:35

New Study Concludes Xlear Kills and/or Deactivates SARS-CoV-2; Efficacy Against New Variants

A new in vitro study done collaboratively by Utah State University and Northwestern University finds Xlear components (grapefruit seed extract and xylitol) significantly eliminates SARS-CoV-2, the vir

January 27, 2021 10:58

Orphan Drug Designation Granted to Rezafungin in EU for the Treatment of Invasive Candidiasis

Mundipharma and Cidara Therapeutics today announced that the European Commission (EC) has now adopted the European Medicines Agency’s (EMA) Committee for Orphan Medicinal Products (COMP) recommendatio

January 26, 2021 14:30

Everbridge Awarded Statewide Vaccine Distribution Deployment Across West Virginia; Everbridge Software Enables Governments, Hospitals and Businesses to Coordinate Rapid Delivery and Communications of COVID-19 Vaccine

Everbridge, Inc. (NASDAQ: EVBG), the global leader in critical event management (CEM), today announced COVID-19 Shield™: Vaccine Distribution, an extension to its CEM platform offering risk insights,

January 25, 2021 14:20

Takeda Named Global Top Employer for Fourth Consecutive Year

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it is one of only 16 companies to achieve global Top Employer® certification for 2021. In addition to receivin

January 22, 2021 10:57

ViiV Healthcare announces FDA approval of Cabenuva (cabotegravir, rilpivirine), the first and only complete long-acting regimen for HIV treatment

ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (“GSK”), with Pfizer Inc. and Shionogi Limited as shareholders, today announced that the US Food and Drug Admin

January 20, 2021 16:45

ARTMS and Isotopia Molecular Imaging Announce Successful Multi-Curie Labeling of PSMA-11 With Cyclotron Produced 68Ga Utilizing the QUANTM Irradiation System™ and Solid Targets

ARTMS Inc. (ARTMS) and Isotopia Molecular Imaging (Isotopia) are pleased to announce the successful radiolabeling of Isotopia’s prostate cancer imaging kit product, PSMA-11, with over 2 Ci of cyclotro

January 19, 2021 17:40

Julie Dehaene-Puype and Erik Nordkamp appointed as new regional Commercial Officers for Mundipharma

FOR MEDICAL BUSINESS/INDUSTRY TRADE MEDIA ONLY The Mundipharma network of independently associated companies today announced two new appointments to their Executive Committee - Julie Dehaene-Puype

News by Region

News by Industry